Viewing Study NCT00960492

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:53 PM
Ignite Modification Date: 2026-01-19 @ 11:01 PM
Study NCT ID: NCT00960492
Status: COMPLETED
Last Update Posted: 2014-09-22
First Post: 2009-08-13
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma
Sponsor: Exelixis
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glioblastoma View
None Giant Cell Glioblastoma View
None Gliosarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Astrocytic tumor View
None Glioblastoma with oligodendroglial components View